EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis

Qingtian Zhu, Chenchen Yuan, Dan Wang, Bo Tu, Weiwei Chen, Xiaowu Dong, Keyan Wu, Lide Tao, Yanbing Ding, Weiming Xiao, Lianghao Hu, Weijuan Gong und 2 weitere

Molecular Therapy · 2024-09 · 32 (9) · 3025-3041

DOI: 10.1016/j.ymthe.2024.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024-09. Verfasst von Qingtian Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pancreatic Center, Department of Gastroenterology, Yangzhou Key Laboratory of Pancreatic Disease, The Affiliated Hospital of Yangzhou University, Yan…. Hauptthemen laut MEDLINE: CD47 Antigen, MicroRNAs, Phagocytosis, Tripartite Motif-Containing Protein 28. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efferocytosis, the clearance of apoptotic cells by macrophages, plays a crucial role in inflammatory responses and effectively prevents secondary necrosis. However, the mechanisms underlying efferocytosis in acute pancreatitis (AP) remain unclear. In this study, we demonstrated the presence of efferocytosis in injured human and mouse pancreatic tissues. We also observed significant upregulation of CD47, an efferocytosis-related the "do not eat me" molecule in injured acinar cells. Subsequently, we used CRISPR-Cas9 gene editing, anti-adeno-associated virus (AAV) gene modification, and anti-CD47 antibody to investigate the potential therapeutic role of AP. CD47 expression was negatively regulated by upstream miR133a, which is controlled by the transcription factor TRIM28. To further investigate the regulation of efferocytosis and reduction of pancreatic necrosis in AP, we used miR-133a-agomir and pancreas-specific AAV-shTRIM28 to modulate CD47 expression. Our findings confirmed that CD47-mediated efferocytosis is critical for preventing pancreatic necrosis and suggest that targeting the TRIM28-miR133a-CD47 axis is clinically relevant for the treatment of AP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD47 AntigenMicroRNAsPhagocytosisTripartite Motif-Containing Protein 28AnimalsMiceHumansMacrophagesPancreasApoptosisDisease Models, AnimalPancreatitis, Acute NecrotizingNecrosisGene Expression RegulationSignal TransductionMaleEfferocytosis

Stichwörter der Autor:innen

acute pancreatitisapoptotic cell clearanceclinical translationimmune microenvironment

Substanzen

CD47 AntigenMicroRNAsTripartite Motif-Containing Protein 28CD47 protein, humanMirn133 microRNA, mouse

Autor:innen und Institutionen

  • Pancreatic Center, Department of Gastroenterology, Yangzhou Key Laboratory of Pancreatic Disease, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225000, China.
  • Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.
  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Department of Gastroenterology, Clinical Medical College, Yangzhou University, Yangzhou 225000, China.
  • Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China. Electronic address: zxwht@163.com.
  • Pancreatic Center, Department of Gastroenterology, Yangzhou Key Laboratory of Pancreatic Disease, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225000, China. Electronic address: wjgong@y…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Q., Yuan, C., Wang, D., Tu, B., Chen, W., Dong, X., Wu, K., Tao, L., Ding, Y., Xiao, W., Hu, L., Gong, W., Li, Z., & Lu, G. (2024). The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis. Molecular Therapy, 32(9), 3025-3041. https://doi.org/10.1016/j.ymthe.2024.06.005

Vancouver

Zhu Q, Yuan C, Wang D, Tu B, Chen W, Dong X, et al. The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis. Molecular Therapy. 2024;32(9):3025-3041. doi:10.1016/j.ymthe.2024.06.005

BibTeX
@article{Zhu2024,
  author = {Zhu, Qingtian and Yuan, Chenchen and Wang, Dan and Tu, Bo and Chen, Weiwei and Dong, Xiaowu and Wu, Keyan and Tao, Lide and Ding, Yanbing and Xiao, Weiming and Hu, Lianghao and Gong, Weijuan and Li, Zhaoshen and Lu, Guotao},
  title = {The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis},
  journal = {Molecular Therapy},
  year = {2024},
  volume = {32},
  number = {9},
  pages = {3025--3041},
  doi = {10.1016/j.ymthe.2024.06.005}
}
Kostenlos starten →